Early Feasibility Evaluation of the UniBE Hybrid Closed-loop Insulin Delivery System in Type 1 Diabetes: UBLoop - Genesis

NANot yet recruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

March 1, 2026

Study Completion Date

March 31, 2026

Conditions
Type-1-Diabetes
Interventions
DEVICE

UBLoop System

"Participants (people living with Type-1-Diabetes) will attend a study visit where the UBLoop system will manage insulin delivery via an insulin pump, using blood glucose values from a continuous glucose meter (CGM). Specialized staff and a remote monitoring system, which is integrated into the UBLoop system, will oversee the participants. The investigational product comprises (1) the BernSHELL App, communicating with the CGM and the insulin pump, (2) the UBLoop algorithm receiving CGM data, processing the control algorithm, calculating insulin dosing, checking the safety of the calculated insulin injections, and transmitting instructions to the insulin pump via BernSHELL, (3) the UBLoop Cloud providing secure storage, analytics support, and data backup, (4) DigiCare, monitoring the safety of the study participants and the system's execution flow in real time.~During the intervention, participants will use the Ypsomed myLife YpsoPump (insulin pump) and the Dexcom G6 or G7 CGM."

Trial Locations (1)

3010

Inselspital, Universitätsspital; Universitätsklinik für Diabetologie, Endokrinologie, Ernährungsmedizin & Metabolismus (UDEM), Bern

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

DCB Research AG

OTHER

collaborator

DexCom, Inc.

INDUSTRY

collaborator

Ypsomed Diabetes Care AG

INDUSTRY

lead

University of Bern

OTHER